Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
about
Purinergic signalling and cancerMultidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic DrugsCorrelation between urothelial differentiation and sensory proteins P2X3, P2X5, TRPV1, and TRPV4 in normal urothelium and papillary carcinoma of human bladder.Signalling molecules in the urotheliumNTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.Introduction and perspective, historical note.Purinergic signalling in the urinary tract in health and disease.Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.A critical look at the function of the P2Y11 receptor.Short- and long-term (trophic) purinergic signalling.Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death.Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.Purinergic Signalling: Therapeutic Developments.Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells.P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer
P2860
Q24618782-101C34D9-2B7A-4403-9566-D849556B9B96Q28547426-C5B78EDA-B954-4251-86FC-97A57B32D7C4Q33608790-EFCA9860-76D8-4979-BCF9-BAFE39DB08E0Q34080499-3CEF9C0C-A027-40FB-9C56-64A1C052910DQ34123241-6F26F332-544F-4118-AE70-B6CE465BB7ACQ35521224-776063CA-5C57-4D2A-8B32-04C65FF2D655Q35960093-C0BC7AFB-5CD0-4094-AA9A-8B49E798C549Q37330911-505455FA-4F8E-4760-93F8-D0BFCC2786B7Q37620260-220D557A-CCD7-4A3C-B48B-E57BFFADEF2CQ37848660-8FD66E7A-2287-431E-99E1-36DE417578F2Q38849452-75359865-079A-4CE7-8E1C-738225904B6CQ38885851-43BA858E-C14C-440C-875A-9FA5FC6D3937Q42068171-8FCB8737-6750-4CB3-B149-AE05573DA0A6Q42316250-3529EF9F-FEAD-47E4-89FF-173B06317CE5Q42367885-8498F918-4069-4D8C-BB04-F9E41C69C483Q47306677-2E4C560E-B0B6-49AE-AF95-2B7B28599AF6Q58764032-2612468F-E012-4FA5-90C2-D302F710AB46
P2860
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
@en
type
label
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
@en
prefLabel
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
@en
P2093
P2860
P1433
P1476
Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
@en
P2093
Cecil Thompson
Dimitri Mikhailidis
Geoffrey Burnstock
Majid Shabbir
P2860
P304
P356
10.1111/J.1464-410X.2007.07286.X
P50
P577
2007-10-17T00:00:00Z